Teriflunomide Mylan Európska únia - slovenčina - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Európska únia - slovenčina - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresívami, selektívne imunosupresívami - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Teriflunomide Zentiva Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teriflunomide zentiva

zentiva, k.s., Česká republika - teriflunomid - 59 - immunopraeparata

Teriflunomide Glenmark 14 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teriflunomide glenmark 14 mg

glenmark pharmaceuticals s.r.o., Česká republika - teriflunomid - 59 - immunopraeparata

Aubagio Európska únia - slovenčina - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - roztrúsená skleróza - selektívne imunosupresíva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).